Increased FoxP3 and PD-L1 in non-pCR tissue from early stage HER2 positive breast cancer patients treated with trastuzumab-pertuzumab based regimens.
Force, JM; Howie, LJ; Abbott, S; Bentley, RC; Marcom, PK; Kimmick, GG; Westbrook, KE; Parks, M; Topping, DL; Broadwater, G; Blackwell, KL; Nair, SK
Volume / Issue
Start / End Page
Electronic International Standard Serial Number (EISSN)
International Standard Serial Number (ISSN)
Digital Object Identifier (DOI)